Bortezomib plus intermediate-dose dexamethasone and thalidomide in elderly untreated patients with multiple myeloma: a Chinese experience.
about
Rapid evolving into acute myeloid leukemia in a patient with multiple myeloma and concurrent myelodysplasia after VTD therapyTreatment and prognostic factors for survival in newly diagnosed multiple myeloma patients with bortezomib and dexamethasone regimen: a single Chinese center retrospective study.Real-World Clinical Outcomes in Elderly Chinese Patients with Multiple Myeloma: A Single-Center Experience
P2860
Bortezomib plus intermediate-dose dexamethasone and thalidomide in elderly untreated patients with multiple myeloma: a Chinese experience.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Bortezomib plus intermediate-d ...... myeloma: a Chinese experience.
@ast
Bortezomib plus intermediate-d ...... myeloma: a Chinese experience.
@en
type
label
Bortezomib plus intermediate-d ...... myeloma: a Chinese experience.
@ast
Bortezomib plus intermediate-d ...... myeloma: a Chinese experience.
@en
prefLabel
Bortezomib plus intermediate-d ...... myeloma: a Chinese experience.
@ast
Bortezomib plus intermediate-d ...... myeloma: a Chinese experience.
@en
P2093
P356
P1476
Bortezomib plus intermediate-d ...... myeloma: a Chinese experience.
@en
P2093
Guohua Yang
Hongfeng Guo
Hongli Sun
Jingjue Mao
Xifeng Qian
P304
P356
10.1002/AJH.21734
P577
2010-07-01T00:00:00Z